financetom
Business
financetom
/
Business
/
KKR Buys Portfolio of Four Industrial Warehouses in Florida
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KKR Buys Portfolio of Four Industrial Warehouses in Florida
Oct 22, 2024 12:48 PM

05:37 PM EDT, 10/21/2024 (MT Newswires) -- KKR (KKR) said Monday it purchased a portfolio of four class A industrial warehouses in Central Florida.

The properties, encompassing around 1.2 million square feet, are situated at the junction of Interstate 4 and U.S. Route 27 in southwest Orlando.

The assets are fully leased to five tenants, according to the company.

KKR said it is purchasing the portfolio via its KKR Real Estate Partners Americas III fund.

Financial details of the acquisition were not disclosed.

Price: 140.60, Change: +0.03, Percent Change: +0.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ionis Pharmaceuticals Insider Sold Shares Worth $4,377,054, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $4,377,054, According to a Recent SEC Filing
Oct 3, 2025
03:23 AM EDT, 10/03/2025 (MT Newswires) -- Patrick R. O'Neil, Executive Vice President, Chief Legal Officer & General Counsel, on October 02, 2025, sold 64,664 shares in Ionis Pharmaceuticals ( IONS ) for $4,377,054. Following the Form 4 filing with the SEC, O'Neil has control over a total of 57,130 common shares of the company, with 57,130 shares held directly....
Ionis Pharmaceuticals Insider Sold Shares Worth $1,793,744, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $1,793,744, According to a Recent SEC Filing
Oct 3, 2025
03:23 AM EDT, 10/03/2025 (MT Newswires) -- Eric Swayze, Executive Vice President, Research, on October 01, 2025, sold 27,114 shares in Ionis Pharmaceuticals ( IONS ) for $1,793,744. Following the Form 4 filing with the SEC, Swayze has control over a total of 37,486 common shares of the company, with 37,302 shares held directly and 184 controlled indirectly. SEC Filing:...
Ionis Pharmaceuticals Insider Sold Shares Worth $1,020,210, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $1,020,210, According to a Recent SEC Filing
Oct 3, 2025
03:21 AM EDT, 10/03/2025 (MT Newswires) -- Joseph Baroldi, Executive Vice President, Chief Business Officer, on October 02, 2025, sold 15,000 shares in Ionis Pharmaceuticals ( IONS ) for $1,020,210. Following the Form 4 filing with the SEC, Baroldi has control over a total of 34,997 common shares of the company, with 31,926 shares held directly and 3,071 controlled indirectly....
Ionis Pharmaceuticals Insider Sold Shares Worth $1,100,385, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $1,100,385, According to a Recent SEC Filing
Oct 3, 2025
03:24 AM EDT, 10/03/2025 (MT Newswires) -- Joseph H Wender, Director, on October 01, 2025, sold 16,800 shares in Ionis Pharmaceuticals ( IONS ) for $1,100,385. Following the Form 4 filing with the SEC, Wender has control over a total of 92,035 common shares of the company, with 92,035 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874015/000087401525000246/xslF345X05/edgardoc.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved